Enzon Pharma sells specialty drug division to sigma-tau for as much as $327M plus royalties
Enzon sells specialty drug business for $300M FDA approves J&J’s Cypher stent for use in smaller blood vesselsFDA approves smaller version of J&J stent BRIDGEWATER, N.J. — Medical product conglomerate Johnson & Johnson said Monday the Food and Drug Administration approved a smaller version of its drug-coated stent, Cypher. |
|